Related Posts
ISN Journal summaries on felzartamab for IgA nephropathy and a new anti-podocin ELISA
Kidney International® Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and... read more
ISN Journal summaries on the DIALIZE-Outcomes trial and heat stress nephropathy in CKDu hotspots in India
Kidney International® The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis People... read more
CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes
ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes... read more
Building momentum in CKDu research: Global experts share progress and insights
The mystery of chronic kidney disease of unknown origin (CKDu) continues... read more
From data to impact: What is it like to be part of ISN research initiatives?
From global policy tools to community-driven projects and early-career development, ISN's... read more
Explore the latest ISN Global Trials Focus selections featuring a “Trial of the month” on the effect of dapagliflozin in patients with ADPKD receiving tolvaptan
ISN-ACT Global Trials Focus editorial team member Michele Provenzano summarizes the design... read more
What does the ISN-GKHA tell us about global dialysis trends?
Why do millions of people worldwide still face limited access to... read more
ISN Journal summaries on making CKD research accessible to patients and pregnancy outcomes in kidney transplant recipients
Kidney International® Identifying strategies for disseminating research to patients with chronic kidney... read more
How the ISN-Global Kidney Health Atlas is growing a global community for optimal kidney care
Through robust data collection, international collaboration, and practical insights, the 2023... read more
Inside the ORIGIN study: Visual and video abstracts on atacicept for the treatment of IgA Nephropathy
Watch the video for an animated explanation of the study based... read more
